Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Chemours Company (The) Common Stock (NY:CC)

11.78 +0.09 (+0.77%)
Streaming Delayed Price Updated: 1:20 PM EST, Dec 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Chemours Company (The) Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
7 Super Speculative Meme Stocks That Could Make You Very Rich ↗
For those that want to skip the trip to Vegas and focus on gambling, these are the speculative meme stocks to consider. 
Via InvestorPlace
News headline image
Chemours (CC) Q4 2022 Earnings Call Transcript ↗
CC earnings call for the period ending December 31, 2022. 
Via The Motley Fool
News headline image
Analyst Expectations for Chemours's Future ↗
 
Via Benzinga
News headline image
Chemours's Earnings Outlook ↗
 
Via Benzinga
News headline image
5 Value Stocks To Watch In The Basic Materials Sector ↗
 
Via Benzinga
News headline image
Finding 20 Dividend Growth Stocks In A Bad Market ↗
Starting in 2012, it became more and more difficult for prudent dividend growth stock investors looking for income. The stock market was trading at excessive valuations, and interest rates were at... 
Via Talk Markets
Overview Of Value Stocks In The Basic Materials Sector ↗
 
Via Benzinga
News headline image
Where Chemours Stands With Analysts ↗
Within the last quarter, Chemours (NYSE:CC) has observed the following analyst ratings: 
Via Benzinga
News headline image
Chemours (CC) Q3 2022 Earnings Call Transcript ↗
CC earnings call for the period ending September 30, 2022. 
Via The Motley Fool
News headline image
Earnings Scheduled For October 25, 2022 ↗
Companies Reporting Before The Bell • UBS Gr (NYSE:UBS) is expected to report earnings for its third quarter. • SAP (NYSE:SAP) is expected to report earnings for its third quarter. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 24, 2023 ↗
 
Via Benzinga
News headline image
This Industrial Stock Looks Dirt Cheap. Is It a Buy? ↗
There is a lot to like about The Chemours Company, but there is one issue that should give investors pause. 
Via The Motley Fool
News headline image
10 Spin-Off Stocks That Pay Dividends ↗
10 spin-offs from recent years that now pay dividends after being separated from their parent companies. 
Via Talk Markets
News headline image
Analyst Ratings for Chemours ↗
Chemours (NYSE:CC) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
Expert Ratings for Chemours ↗
Analysts have provided the following ratings for Chemours (NYSE:CC) within the last quarter: 
Via Benzinga
News headline image
3 Undervalued Cruise Stocks to Buy Now ↗
These undervalued cruise stocks have bounced back exceedingly well from the pandemic-led weakness and are benefitting from pent-up demand. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For January 11, 2023 ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2022 ↗
Upgrades 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 10, 2023 ↗
 
Via Benzinga
News headline image
Analyst Ratings for Chemours ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022 ↗
Upgrades 
Via Benzinga
News headline image
McDonald's Price Target Cut By This Analyst, Plus Cowen Predicts $362 For Domino's Pizza ↗
Citigroup cut McDonald's Corporation (NYSE: MCD) price target from $275 to $246. McDonald's shares rose 0.5% to $245.00 in pre-market trading. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Spero Therapeutics To Rally Around 240%? Plus This Analyst Slashes PT On Salesforce ↗
Evercore ISI Group raised the price target on Spero Therapeutics, Inc. (NASDAQ: SPRO) from $2 to $8. Evercore ISI Group analyst Josh Schimmer also upgraded the stock from In-Line to Outperform. Spero... 
Via Benzinga
News headline image
UnitedHealth To Rally 24%? Here Are 5 Other Price Target Changes For Thursday ↗
Raymond James raised the price target on UnitedHealth Group Incorporated (NYSE: UNH) from $620 to $635. Raymond James analyst John Ransom maintained the stock with a Strong Buy rating. UnitedHealth... 
Via Benzinga
News headline image
Chemours, Alcoa And Other Big Losers From Wednesday ↗
U.S. stocks closed lower with the Dow Jones dropping more than 500 points on Tuesday. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
News headline image
UBS Maintains Neutral Rating for Chemours: Here's What You Need To Know ↗
UBS has decided to maintain its Neutral rating of Chemours (NYSE:CC) and raise its price target from $35.00 to $37.00. Shares of Chemours are trading up 3.55% over the last 24 hours, at $36.14 per... 
Via Benzinga
News headline image
5 Analysts Have This to Say About Chemours ↗
Over the past 3 months, 5 analysts have published their opinion on Chemours (NYSE:CC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's... 
Via Benzinga
News headline image
Recap: Chemours Q2 Earnings ↗
Chemours (NYSE:CC) reported its Q2 earnings results on Thursday, July 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Chemours beat estimated earnings by... 
Via Benzinga
News headline image
How Does The Need Of Marketization Of HFCVs Impact PEM Industry? ↗
As carbon neutral is becoming a consensus, the marketization of HFCVs is accelerating all over the world with its zero-carbon emission. 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.